NORTHERN TRUST CORP - AIM IMMUNOTECH INC ownership

AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 38 filers reported holding AIM IMMUNOTECH INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of AIM IMMUNOTECH INC
ValueSharesWeighting
Q3 2023$38,933
-32.8%
85,566
-1.1%
0.00%
Q2 2023$57,966
+55.8%
86,5170.0%0.00%
Q1 2023$37,202
+37.9%
86,5170.0%0.00%
Q4 2022$26,985
-46.0%
86,5170.0%0.00%
Q3 2022$50,000
-27.5%
86,517
-2.5%
0.00%
Q2 2022$69,000
-26.6%
88,7070.0%0.00%
Q1 2022$94,000
+14.6%
88,707
+0.1%
0.00%
Q4 2021$82,000
-54.2%
88,662
+0.3%
0.00%
Q3 2021$179,000
-4.8%
88,416
+1.4%
0.00%
Q2 2021$188,000
+22.1%
87,226
+28.8%
0.00%
Q1 2021$154,000
+33.9%
67,746
+5.4%
0.00%
Q4 2020$115,000
-17.9%
64,303
-1.5%
0.00%
Q3 2020$140,000
-2.1%
65,267
+13.4%
0.00%
Q2 2020$143,00057,5660.00%
Other shareholders
AIM IMMUNOTECH INC shareholders Q1 2022
NameSharesValueWeighting ↓
ForthRight Wealth Management, LLC 20,000$9,1000.00%
D.B. Root & Company, LLC 12,050$5,4830.00%
SeaCrest Wealth Management, LLC 37,063$16,8640.00%
SNS Financial Group, LLC 10,000$4,5500.00%
Virtu Financial LLC 29,061$130.00%
VisionPoint Advisory Group, LLC 3,142$1,4300.00%
Community Bank, N.A. 13,226$5,9510.00%
Verition Fund Management LLC 148,000$67,3400.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 108,900$49,5500.00%
Traynor Capital Management, Inc. 11,777$5,3590.00%
View complete list of AIM IMMUNOTECH INC shareholders